Invests in
Sectors:
Locations:
Min Investment:
$500,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Martin
Work Experience
2024
Director
2024
MBX is a venture capital partnership focused on emerging companies pursuing critical challenges in public health. We invest between $500K and $5mm into early-stage bio/health-tech companies. Learn more at mbxcapital.com
2016 - 2024
Director, Strategic Finance
2016 - 2024
V3 Commodities Group provides physical energy commodity products and services alongside capital support to retail energy providers operating in the North American energy markets. We also provide M&A services related to the acquisition and disposition of assets related to the sector.
2018 - 2019
Corporate Development
2018 - 2019
Mergers and acquisitions for Roivant Sciences, Inc., as of early 2020 a $9B market cap healthcare firm with ~20 portfolio biopharma companies developing treatments for 35+ indications across a range of therapeutic areas and modalities